Epigenetic drugs could protect blood vessels in obesity and diabetesScientists from Zurich, together with colleagues from Italy, have proved that by acting on epigenetic "switches", early damage to blood vessels can be reversed. People with obesity and type 2 diabetes are at increased risk of cardiovascular complications. However, the danger depends not only on heredity, but also on how genes work.
Non-atherosclerotic myocardial infarction in hypereosinophilic syndrome: emerging insights and therapeutic approachesHypereosinophilic syndrome (HES) is a heterogeneous disorder characterised by persistent, abnormal eosinophil elevation in blood and tissues, with multisystem involvement. Cardiac manifestations are frequent in HES and significantly worsen prognosis. Recent evidence establishes a direct link between HES and myocardial infarction (MI), demonstrating that HES induces MI primarily via non-atherosclerotic mechanisms.